Literature DB >> 21394616

Repeated measurements of endothelin-1 precursor peptides predict the outcome in community-acquired pneumonia.

Philipp Schuetz1, Mirjam Christ-Crain, Werner Zimmerli, Beat Mueller.   

Abstract

PURPOSE: Excessive activation of the endothelium is associated with adverse outcomes in patients with systemic infections. Endothelium-associated peptides, such as endothelin-1 (ET-1), correlate closely with endothelial activation, and therefore serve as surrogate biomarkers. Our aim was to investigate precursor peptides of endothelin-1 (proET1) on admission and during follow-up on days 3, 5 and 7 in a prospective cohort of 925 patients with community-acquired pneumonia.
METHODS: We investigated the association of initial and follow-up proET1 and other prohormone levels with 30-day mortality and ICU admission in proportional Cox regression models with time-varying covariates adjusted for the pneumonia-severity-index (PSI), and calculated reclassification statistics.
RESULTS: The mortality rate and ICU admission rate were 5.4% (95% CI 3.9-6.8%) and 9.0% (95% CI 7.1-10.8%). ProET1 levels on admission and changes from baseline to day 3 were significant mortality predictors with adjusted hazard ratios of 10.5 (95% CI 2.9-38.6) and 28.4 (95% CI 7.0-115.1). Initial proET1 levels improved the PSI in reclassification statistics (net reclassification improvement of 0.29, p<0.0001) and in c-statistics (from 0.79 to 0.83, p<0.01). Changes of proET1 on day 3 improved the c-statistic of the combined model of PSI and initial proET1 from 0.80 to 0.85 (p<0.01) and reclassification tables demonstrated a significant improvement (net reclassification improvement 0.44, p<0.0001). Similar significant results were found for the risk for ICU admission.
CONCLUSIONS: In community-acquired pneumonia, ET-1 precursor peptides on admission and changes from baseline to day 3 were independent predictors for mortality and ICU admission, and significantly improved the PSI. If verified in intervention studies, monitoring of proET1 may be helpful for endothelium targeting therapies and for risk stratification complementary to other prohormones. © Copyright jointly held by Springer and ESICM 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21394616     DOI: 10.1007/s00134-011-2208-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  49 in total

1.  Sepsis and endothelial permeability.

Authors:  Warren L Lee; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

Review 2.  Burden of community-acquired pneumonia in North American adults.

Authors:  Thomas M File; Thomas J Marrie
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

3.  Endothelins in health and disease.

Authors:  Rahman Shah
Journal:  Eur J Intern Med       Date:  2007-07       Impact factor: 4.487

4.  Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock.

Authors:  Vladimir Krejci; Luzius B Hiltebrand; Dominique Erni; Gisli H Sigurdsson
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

5.  The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock.

Authors:  A Oldner; M Wanecek; M Goiny; E Weitzberg; A Rudehill; K Alving; A Sollevi
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

6.  Increased concentrations of endothelin-1 messenger RNA in tissues and endothelin-1 peptide in plasma in septic pigs: modulation by betamethasone.

Authors:  A Hemsén; A Modin; E Weitzberg
Journal:  Crit Care Med       Date:  1996-09       Impact factor: 7.598

7.  Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Authors:  Philipp Schuetz; Marcel Wolbers; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Thomas Fricker; Claudine Blum; Ursula Schild; Nils G Morgenthaler; Ronald Schoenenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Mueller
Journal:  Crit Care       Date:  2010-06-08       Impact factor: 9.097

Review 8.  Year in review in Intensive Care Medicine, 2006. II. Infections and sepsis, haemodynamics, elderly, invasive and noninvasive mechanical ventilation, weaning, ARDS.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel De Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Duncan Macrae; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerôme Pugin; Michael Pinsky; Peter Radermacher; Christian Richard
Journal:  Intensive Care Med       Date:  2007-01-13       Impact factor: 17.440

9.  Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.

Authors:  Philipp Schuetz; Mirjam Christ-Crain; Marcel Wolbers; Ursula Schild; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Claudine A Blum; Ronald Schönenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Müller
Journal:  BMC Health Serv Res       Date:  2007-07-05       Impact factor: 2.655

10.  Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.

Authors:  Philipp Schuetz; Daiana Stolz; Beat Mueller; Nils G Morgenthaler; Joachim Struck; Christian Mueller; Roland Bingisser; Michael Tamm; Mirjam Christ-Crain
Journal:  BMC Infect Dis       Date:  2008-02-28       Impact factor: 3.090

View more
  8 in total

1.  Managing CAP in the ICU.

Authors:  Liapikou Adamantia; Makrodimitri Sotiria; Melaxroinidou Myrsini; Toumbis Michael
Journal:  Curr Infect Dis Rep       Date:  2015-11       Impact factor: 3.725

2.  Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.

Authors:  Javier Benito; Carlos Luaces-Cubells; Santiago Mintegi; Eider Astobiza; Lorea Martinez-Indart; Ana Valls-Lafont; Juan-José García-García
Journal:  Eur J Pediatr       Date:  2013-06-22       Impact factor: 3.183

3.  Optimizing triage and hospitalization in adult general medical emergency patients: the triage project.

Authors:  Philipp Schuetz; Pierre Hausfater; Devendra Amin; Sebastian Haubitz; Lukas Fässler; Eva Grolimund; Alexander Kutz; Ursula Schild; Zeljka Caldara; Katharina Regez; Andriy Zhydkov; Timo Kahles; Krassen Nedeltchev; Stefanie von Felten; Sabina De Geest; Antoinette Conca; Petra Schäfer-Keller; Andreas Huber; Mario Bargetzi; Ulrich Buergi; Gabrielle Sauvin; Pasqualina Perrig-Chiello; Barbara Reutlinger; Beat Mueller
Journal:  BMC Emerg Med       Date:  2013-07-04

Review 4.  Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-20       Impact factor: 17.440

5.  Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study.

Authors:  Martin Kolditz; Gert Höffken; Peter Martus; Gernot Rohde; Hartwig Schütte; Robert Bals; Norbert Suttorp; Mathias W Pletz
Journal:  BMC Infect Dis       Date:  2012-04-13       Impact factor: 3.090

6.  Joint Modeling of Repeated Measurements of Different Biomarkers Predicts Mortality in COVID-19 Patients in the Intensive Care Unit.

Authors:  Kirby Tong-Minh; Yuri van der Does; Joost van Rosmalen; Christian Ramakers; Diederik Gommers; Eric van Gorp; Dimitris Rizopoulos; Henrik Endeman
Journal:  Biomark Insights       Date:  2022-07-14

Review 7.  Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Christophe Marti; Nicolas Garin; Olivier Grosgurin; Antoine Poncet; Christophe Combescure; Sebastian Carballo; Arnaud Perrier
Journal:  Crit Care       Date:  2012-07-27       Impact factor: 9.097

Review 8.  Hot topics and current controversies in community-acquired pneumonia.

Authors:  Diego Severiche-Bueno; Daniela Parra-Tanoux; Luis F Reyes; Grant W Waterer
Journal:  Breathe (Sheff)       Date:  2019-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.